Insider Trading & Ownership - Regulus Therapeutics Inc. (RGLS)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Regulus Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-03-01
Purchase		 2022-03-01
5:58 pm		 Regulus Therapeutics Inc. RGLS Drygin Denis
Chief Scientific Officer		 76,686 $0.23 $17,638 100,000
(Direct)		 View
2022-02-04
Purchase		 2022-02-07
5:09 pm		 Regulus Therapeutics Inc. RGLS Drygin Denis
Chief Scientific Officer		 23,314 $0.23 $5,362 23,314
(Direct)		 View
2022-01-26
Purchase		 2022-01-26
4:13 pm		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 100,000 $0.2152 $21,520 2,017,006
(Direct)		 View
2021-05-17
Sale		 2021-05-17
7:13 pm		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 4,186 $0.89 $3,726 316,292
(Direct)		 View
2021-05-17
Sale		 2021-05-17
7:12 pm		 Regulus Therapeutics Inc. RGLS Aker Christopher Ray
Sr. VP & General Counsel		 860 $0.89 $765 41,754
(Direct)		 View
2021-02-16
Sale(A)		 2021-04-16
4:11 pm		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 4,144 $1.72 $7,128 244,628
(Direct)		 View
2021-02-16
Sale		 2021-02-17
5:23 pm		 Regulus Therapeutics Inc. RGLS Aker Christopher Ray
Sr. VP & General Counsel		 828 $1.72 $1,424 42,614
(Direct)		 View
2021-02-16
Sale		 2021-02-17
5:23 pm		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 4,144 $1.72 $7,128 485,756
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-05-09
Option Award		 2022-05-11
4:31 pm		 N/A
2030-01-20		 Regulus Therapeutics Inc. RGLS Aker Christopher Ray
Sr. VP & General Counsel		 70,000 $0 70,000
(Direct)		 View
2022-01-12
Option Award		 2022-01-26
4:14 pm		 N/A
2032-01-11		 Regulus Therapeutics Inc. RGLS Drygin Denis
Chief Scientific Officer		 400,000 $0 400,000
(Direct)		 View
2022-01-12
Option Award		 2022-01-26
4:13 pm		 N/A
2032-01-11		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 1,600,000 $0 2,017,006
(Direct)		 View
2022-01-12
Option Award		 2022-01-26
4:12 pm		 N/A
2032-01-11		 Regulus Therapeutics Inc. RGLS CALSADA CRISPINA
Chief Financial Officer		 480,000 $0 480,000
(Direct)		 View
2022-01-12
Option Award		 2022-01-26
4:11 pm		 N/A
2032-01-11		 Regulus Therapeutics Inc. RGLS Aker Christopher Ray
Sr. VP & General Counsel		 480,000 $0 480,000
(Direct)		 View
2021-11-30
Option Award		 2021-12-01
4:12 pm		 N/A
N/A		 Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director		 2,222,222 $0.36 5,061,929
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
5:17 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Simeonidis Simos
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:46 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Witz Pascale
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:45 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Rosen Hugh
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:44 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS RASTETTER WILLIAM H
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:43 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:43 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Nunn Jason Raleigh
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:42 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Huang Alice Shih-hou
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:40 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS Collier Kathryn J
Director		 40,000 $0 40,000
(Direct)		 View
2021-06-14
Option Award		 2021-06-15
4:39 pm		 N/A
2031-06-13		 Regulus Therapeutics Inc. RGLS BALTIMORE DAVID
Director		 40,000 $0 40,000
(Direct)		 View
2021-04-14
Conversion		 2021-04-16
4:12 pm		 N/A
N/A		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 83,435 $0 320,478
(Indirect)		 View
2021-02-04
Option Award		 2021-02-05
5:01 pm		 N/A
2031-02-04		 Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO		 600,000 $0 600,000
(Direct)		 View
2021-02-04
Option Award		 2021-02-05
5:00 pm		 N/A
2031-02-04		 Regulus Therapeutics Inc. RGLS Drygin Denis
Chief Scientific Officer		 120,000 $0 120,000
(Direct)		 View
2021-02-04
Option Award		 2021-02-05
4:58 pm		 N/A
2031-02-04		 Regulus Therapeutics Inc. RGLS CALSADA CRISPINA
Chief Financial Officer		 150,000 $0 150,000
(Direct)		 View
2021-02-04
Option Award		 2021-02-05
4:57 pm		 N/A
2031-02-04		 Regulus Therapeutics Inc. RGLS Aker Christopher Ray
Sr. VP & General Counsel		 180,000 $0 180,000
(Direct)		 View
2021-01-26
Option Award		 2021-01-27
8:32 pm		 N/A
2031-01-26		 Regulus Therapeutics Inc. RGLS Huang Alice Shih-hou
BALTIMORE DAVID
Director		 80,000 $0 80,000
(Direct)		 View

Ownership		 2021-01-27
8:24 pm		 N/A
N/A		 Regulus Therapeutics Inc. RGLS Huang Alice Shih-hou
Director		 0 $0 95,354
(Indirect)		 View
2020-12-04
Option Award(A)		 2021-01-27
8:16 pm		 N/A
N/A		 Regulus Therapeutics Inc. RGLS PAPADOPOULOS STELIOS
Director		 793,528 $0.6301 2,839,707
(Direct)		 View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2, 3, Next